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RExercise Restrictions After
Balloon Aortic Valvuloplasty
We read with interest the study of outcomes after balloon aortic
valvuloplasty recently published by Brown et al. (1), and the
accompanying editorial by Rome (2). The authors have valuably
demonstrated the outcome of patients who have had balloon aortic
valvuloplasty and shown that sudden death in this young patient
population is rare. Their paper and Dr. Rome’s editorial also
remind readers that any recommendations for exercise restrictions
in these patients are not evidence-based and that such restrictions
have risks as well as benefits.
Many of us rely upon the 36th Bethesda Conference guidelines
(3) when imposing restrictions on our young patients. These
guidelines, however, are intended for competitive athletes and not
for young children. They are stated to be “most easily applied to
high school, college, and professional sports” with deference to the
clinician’s individual judgment for youth sports activities, “partic-
ularly for those children less than age 12 years” (3).
The authors’ choice to extend the evaluation of exercise restric-
ion in aortic stenosis down to patients as young as 4 years of age
ncreases the number of patient-years in the assessment, but
erhaps not in a meaningful way. In the subgroup of 403 patients
n whom an exercise recommendation could be determined, many
atients were not old enough for such a recommendation to be
pplicable for much of the study period. In those patients with an
xercise restriction, follow-up began at a mean age of 4 years and
asted for an average of 14.4 years. Those in whom there was no
xercise restriction began follow-up at a mean age of 3 years for an
verage duration of 12.1 years. If one limits the data to those
atients old enough to participate in competitive sports, and
urther to those who chose to participate, the study sample size and
vailable years of follow-up would decrease significantly. To
ppropriately assess the population of young athletes at highest
heoretic risk for life-threatening events will likely require a larger,
ulticenter study.
Brown et al. (1) should be congratulated for lighting a candle in
he darkness of our understanding of sudden death in the context
f aortic stenosis, and they raise important questions about our
ecommendations for our patients’ activity. Unfortunately, it is still
retty dark out there.
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Reply
We thank Drs. Hokanson and Ralphe for their interest in our
paper and comments on our findings (1). Although the Bethesda
Conference guidelines were written to apply to patients 12 years of
age and older, this age was arbitrarily chosen by the consensus
committee as an age at which participation in organized sports
with systematic (usually intense) training and regular competition
becomes common. However, the consensus panel clearly recog-
nized the possibility of application to all ages, and noted that
clinicians “may want to use individual judgment in defining
competitive forms of physical activity . . . particularly those for
children less than age 12 years” (2). In our experience, organized
athletics with intense training and competition are quite common
in the United States in those younger than age 12 years, and many
clinicians do apply these restrictions to patients as young as 4 years;
hence, we chose to include those patient-years in our follow-up.
The assumption that any exercise-associated risk of sudden
death is highest in young athletes is based on theoretical consid-
erations and not on documented risk. We agree that it requires
extremely large studies to establish an absence of risk. Unfortu-
nately, case reports and case series that are void of any statistical
considerations are often accepted as evidence of risk and, in the
absence of better data, are used to develop consensus guidelines.
This situation is quite parallel to the recommendations for sub-
acute bacterial endocarditis prophylaxis in patients with congenital
heart disease, where case reports rather than population-based
studies of endocarditis were used to justify population-wide man-
agement, recommendations that have subsequently been rescinded.
This prejudice is prevalent throughout medicine and proceeds
from the justifiable desire to minimize risks. However, as is the
case with young patients with aortic stenosis, sometimes avoidance
of theoretical risk means exclusion of activities with clinically
proven benefit.
The issue the practicing clinician faces on a daily basis is
whether a theoretical, but unproven, risk should prompt an
exclusion from athletics participation with all of the extremely
well-documented benefits of vigorous exercise. The risk-benefit
considerations here are quite complex because regular exercise
participation has been clearly documented to reduce overall risk of
sudden death, even if there is a transient increase in risk during
exercise (3–7). It is therefore insufficient to proceed on data
collected only during exercise participation, which is the nature of
